Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Docetaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer

NCT01462149 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01462149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01462149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Docetaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
Lead sponsor
Asan Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
June 30, 2016
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced ovarian cancer